S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
NASDAQ:RIBT

RiceBran Technologies (RIBT) Stock Price, News & Analysis

$0.13
-0.06 (-31.58%)
(As of 11:35 AM ET)
Today's Range
$0.13
$0.13
50-Day Range
$0.09
$0.21
52-Week Range
$0.07
$1.17
Volume
125 shs
Average Volume
21,969 shs
Market Capitalization
$1.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RIBT stock logo

About RiceBran Technologies Stock (NASDAQ:RIBT)

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally. It focuses on development, production, and marketing of products derived from rice and other small and ancient grains for the nutraceutical, healthy food, companion animal, and equine feed categories. The company converts raw rice bran into stabilized rice bran (SRB) and high value SRB derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate, and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. It serves food and animal nutrition manufacturers, wholesalers, and retailers. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

RIBT Stock Price History

RIBT Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
RiceBran Technologies Sells Golden Ridge Milling Facility
RiceBran Technologies Reports Third Quarter 2023 Results
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
RiceBran Technologies RIBT
RiceBran Technologies Sells SRB Business
Q1 2023 RiceBran Technologies Earnings Call
See More Headlines
Receive RIBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RiceBran Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/27/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Grain mill products
Sub-Industry
N/A
Current Symbol
NASDAQ:RIBT
Employees
94
Year Founded
N/A

Profitability

Net Income
$-7,860,000.00
Pretax Margin
-26.61%

Debt

Sales & Book Value

Annual Sales
$41.62 million
Book Value
$2.03 per share

Miscellaneous

Free Float
8,940,000
Market Cap
$1.24 million
Optionable
Not Optionable
Beta
0.46
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Eric Tompkins (Age 63)
    Executive Chairman
  • Mr. William J. Keneally (Age 61)
    Interim CFO & Secretary
  • Dr. Rani Madhavapeddi Patel
    Chief Science Officer
  • Ms. Sherry Rhoads
    Vice President of Compliance, Regulatory & External Affairs
  • Dr. Joseph Gutman M.D.
    Strategic Consultant & Member of Medical Advisory Board

RIBT Stock Analysis - Frequently Asked Questions

How have RIBT shares performed in 2024?

RiceBran Technologies' stock was trading at $0.2325 at the beginning of the year. Since then, RIBT shares have decreased by 18.3% and is now trading at $0.19.
View the best growth stocks for 2024 here
.

How were RiceBran Technologies' earnings last quarter?

RiceBran Technologies (NASDAQ:RIBT) released its quarterly earnings data on Wednesday, October, 27th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.20. The company earned $6.91 million during the quarter. RiceBran Technologies had a negative net margin of 51.01% and a negative trailing twelve-month return on equity of 122.53%.

When did RiceBran Technologies' stock split?

RiceBran Technologies shares reverse split on the morning of Friday, August 26th 2022. The 1-10 reverse split was announced on Friday, August 26th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of RiceBran Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RiceBran Technologies investors own include OPKO Health (OPK), vTv Therapeutics (VTVT), Pareteum (TEUM), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Palatin Technologies (PTN), Trevena (TRVN), VBI Vaccines (VBIV), Vistagen Therapeutics (VTGN) and Alimera Sciences (ALIM).

How do I buy shares of RiceBran Technologies?

Shares of RIBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RIBT) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners